Bracco Diagnostics has obtained the US Food and Drug Administration (FDA) clearance for use of its MultiHance (gadobenate dimeglumine) injection, 529 mg/mL, in magnetic resonance angiography (MRA), designed to evaluate adults with known or ...
Tags: FDA, Bracco, clearance, MultiHance injection, MRA
The Bracco Diagnostics has gained FDA approval for the use of MultiHance(gadobenate dimeglumine)injection,529mg/ml,in magnetic resonance angiography(MRA)to evaluate adults with known or suspected renal or aorto-ilio-femoral occlusive ...